Chemokines in Chronic Liver Allograft Dysfunction Pathogenesis and Potential Therapeutic Targets
Despite advances in immunosuppressive drugs, long-term success of liver transplantation is still limited by the development of chronic liver allograft dysfunction. Although the exact pathogenesis of chronic liver allograft dysfunction remains to be established, there is strong evidence that chemokin...
Saved in:
| Main Authors: | Bin Liu, Jing Li, Lu-Nan Yan |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2013-01-01
|
| Series: | Clinical and Developmental Immunology |
| Online Access: | http://dx.doi.org/10.1155/2013/325318 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
CXCL4 Contributes to the Pathogenesis of Chronic Liver Allograft Dysfunction
by: Jing Li, et al.
Published: (2016-01-01) -
Hepatic macrophages in liver fibrosis: pathogenesis and potential therapeutic targets
by: Hai Li, et al.
Published: (2016-05-01) -
Antithymocyte globulin therapy in chronic lung allograft dysfunction
by: Akhilesh Ajay Padhye, et al.
Published: (2025-07-01) -
Late liver allograft dysfunction: definition, risk factors and outcomes
by: Yu. O. Malinovskaya, et al.
Published: (2024-06-01) -
The impact of late liver allograft dysfunction on physical activity of liver transplant recipients
by: Yu. O. Malinovskaya, et al.
Published: (2021-12-01)